ReleaseWire Connect

Leaders in Pharmaceutical Business Intelligence (LBPI Group), launched in April 2012 as an Open Access Online Scientific Journal (http://pharmaceuticalintelligence.com), has reached over 1 million unique site visits, with approximately 30,000 monthly views, +2,115 followers, and 300 sites linking into the journal, including ncbi.nlm.nih.gov, Nature.com, commons.wikipedia.org, dx.doi.org, NEJM, personalizedmedicine.partners.org, cancer.gov, medscape.com, masspec.scripps.edu, and sciencedirect.com.

Leaders in Pharmaceutical Business Intelligence would like to announce the First volume of their BioMedical E-Book Series B: Genomics Orientations for Individualized Medicine, Vol. I

Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation which is now available on Amazon Kindle at www.amazon.com/dp/B018Q5MCN8.

Volume Four: Therapeutic Promise: Cardiovascular Diseases, Regenerative & Translational Medicine which is now available on Amazon Kindle at www.amazon.com/dp/B019UM909A.

Leaders in Pharmaceutical Business Intelligence would like to announce Volume III of their BioMedical E-Book Series E: Patient-Centered Medicine

Leaders in Pharmaceutical Business Intelligence would like to announce the Third volume of their BioMedical E-Book Series A: e-Books on Cardiovascular Diseases

Leaders in Pharmaceutical Business Intelligence would like to announce the First volume of their BioMedical E-Book Series C: e-Books on Cancer & Oncology

This e-Book is a comprehensive review of recent Original Research on METABOLOMICS and related opportunities for Targeted Therapy written by Experts, Authors, Writers. This is the first volume of the Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases. It is written for comprehension at the third year medical student level, or as a reference for licensing board exams, but it is also written for the education of a first time baccalaureate degree reader in the biological sciences. Hopefully, it can be read with great interest by the undergraduate student who is undecided in the choice of a career. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation. The e-Book's articles have been published on the Open Access Online Scientific Journal, since April 2012. All new articles on this subject, will continue to be incorporated, as published with periodical updates.

Over 500,000 Unique Site Visits reached by pharmaceuticalintelligence.com Reported today by Leaders in Pharmaceutical Business Intelligence (LBPI)

Leaders in Pharmaceutical Business Intelligence, launched in April 2012 as an Open Access Online Scientific Journal, would like to announce the FIRST book of their BioMedical E-Book Series, Perspectives on Nitric Oxide in Disease Mechanisms, which is now available on Amazon Kindle. This book is a comprehensive review of Nitric Oxide, its discovery, function, and related opportunities for targeted therapy written by PhDs, MDs, MD/PhDs, PharmDs.